Taivex Therapeutics’ three clinical projects have been selected to present their project progress at the AACR Annual Meeting 2024
Taivex has announced that all three Phase I clinical projects, T-1101, T-1201, and T-1301, have been selected to present their project progress at the American Association for Cancer Research (AACR) Annual Meeting 2024 in San Diego, California. At the conference, unveil for this is the first time to unveil relevant data including chemical structures, product …
